[go: up one dir, main page]

WO2013055073A3 - 사이클로스포린 함유 안약 조성물 및 그 제조방법 - Google Patents

사이클로스포린 함유 안약 조성물 및 그 제조방법 Download PDF

Info

Publication number
WO2013055073A3
WO2013055073A3 PCT/KR2012/008160 KR2012008160W WO2013055073A3 WO 2013055073 A3 WO2013055073 A3 WO 2013055073A3 KR 2012008160 W KR2012008160 W KR 2012008160W WO 2013055073 A3 WO2013055073 A3 WO 2013055073A3
Authority
WO
WIPO (PCT)
Prior art keywords
ophthalmic composition
composition containing
preparing same
cyclosporine
containing cyclosporine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/008160
Other languages
English (en)
French (fr)
Other versions
WO2013055073A2 (ko
Inventor
김용남
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2851131A priority Critical patent/CA2851131A1/en
Priority to US14/351,099 priority patent/US20140302099A1/en
Publication of WO2013055073A2 publication Critical patent/WO2013055073A2/ko
Publication of WO2013055073A3 publication Critical patent/WO2013055073A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 유효성분으로 사이클로스포린을 함유하며, 프로필렌글리콜, 계면활성제 및 정제수를 포함하는 안약 조성물 및 그 제조방법에 관한 것으로, 본 발명의 안약 조성물은 맑고 투명한 용액형태로서, 시야 흐림, 작열감 등의 부작용이 없어 환자의 복약순응도가 증대되고, 표적 기관인 안구조직으로의 사이클로스포린의 흡수가 개선되어 생체 이용성이 높다.
PCT/KR2012/008160 2011-10-10 2012-10-09 사이클로스포린 함유 안약 조성물 및 그 제조방법 Ceased WO2013055073A2 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2851131A CA2851131A1 (en) 2011-10-10 2012-10-09 Ophthalmic composition containing cyclosporin and method for preparing same
US14/351,099 US20140302099A1 (en) 2011-10-10 2012-10-09 Ophthalmic Composition Containing Cyclosporine And method For Preparing Same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20110102909A KR101510764B1 (ko) 2011-10-10 2011-10-10 사이클로스포린 함유 안약 조성물 및 그 제조방법
KR10-2011-0102909 2011-10-10

Publications (2)

Publication Number Publication Date
WO2013055073A2 WO2013055073A2 (ko) 2013-04-18
WO2013055073A3 true WO2013055073A3 (ko) 2013-07-04

Family

ID=48082640

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/008160 Ceased WO2013055073A2 (ko) 2011-10-10 2012-10-09 사이클로스포린 함유 안약 조성물 및 그 제조방법

Country Status (4)

Country Link
US (1) US20140302099A1 (ko)
KR (1) KR101510764B1 (ko)
CA (1) CA2851131A1 (ko)
WO (1) WO2013055073A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101587385B1 (ko) 2015-07-29 2016-01-21 국제약품공업주식회사 사이클로스포린 함유 무자극성의 안약조성물 및 편리한 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
WO2002013792A1 (fr) * 2000-08-11 2002-02-21 Eisai Co., Ltd. Dispersion solide médicamenteuse à solubilité accrue
KR20100107462A (ko) * 2008-01-04 2010-10-05 알콘 파아마슈티칼스 리미티드 안정한 수성 시클로스포린 조성물
KR101008189B1 (ko) * 2010-07-29 2011-01-17 에스씨바이오팜 주식회사 안구건조증 치료용 사이클로스포린 함유 안과용 나노에멀젼 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148224A1 (en) * 2005-12-28 2007-06-28 Discovery Partners Llc Skin treatment compositions containing copper-pigment complexes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
WO2002013792A1 (fr) * 2000-08-11 2002-02-21 Eisai Co., Ltd. Dispersion solide médicamenteuse à solubilité accrue
KR20100107462A (ko) * 2008-01-04 2010-10-05 알콘 파아마슈티칼스 리미티드 안정한 수성 시클로스포린 조성물
KR101008189B1 (ko) * 2010-07-29 2011-01-17 에스씨바이오팜 주식회사 안구건조증 치료용 사이클로스포린 함유 안과용 나노에멀젼 조성물

Also Published As

Publication number Publication date
KR101510764B1 (ko) 2015-04-10
US20140302099A1 (en) 2014-10-09
CA2851131A1 (en) 2013-04-18
WO2013055073A2 (ko) 2013-04-18
KR20130038512A (ko) 2013-04-18

Similar Documents

Publication Publication Date Title
HK1211867A1 (en) Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
MX2023003124A (es) Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
HK1215934A1 (zh) 肽治疗剂及其使用方法
WO2013171204A3 (de) Ophthalmologisches vehikelsystem
NZ732777A (en) Ionizable cationic lipid for rna delivery
MY164352A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
WO2012021715A3 (en) Stable formulations of linaclotide
WO2015183963A3 (en) Therapeutic compositions including redox-active parabenzoquinones and uses thereof
EP4410312A3 (en) Topical cyclosporine-containing formulations and uses thereof
WO2009117316A3 (en) Pharmaceutical compositions having desirable bioavailability
HK1231376A1 (zh) 局部制剂及其应用
WO2013181339A3 (en) Cyclosporin a analogs
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
WO2012053009A3 (en) Pharmaceutical compositions comprising nano size droplets of skin whitening agents
WO2012161497A3 (ko) 보습능이 우수한 펩타이드 유도체 및 이의 용도
HK1216839A1 (zh) 调整释放制剂
WO2014161004A3 (en) Compositions and methods for the delivery of drugs to the ocular surface by contact lenses
EP4403220A3 (en) Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
IN2014CN02972A (ko)
WO2012099899A3 (en) Topical dermatological compositions for the treatment of acne
WO2013046059A3 (en) Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
WO2017152129A3 (en) Treatment of glaucoma and/or retinal diseases and formulations useful therefore
WO2013055073A3 (ko) 사이클로스포린 함유 안약 조성물 및 그 제조방법
WO2012148200A3 (ko) 허혈성 혈관 질환 치료시술 보조용 조성물
EP4364810A3 (en) Topical formulations and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12840311

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2851131

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 14351099

Country of ref document: US

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 13/08/2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12840311

Country of ref document: EP

Kind code of ref document: A2